Lipids and diabetic retinopathy in newly diagnosed type 2 diabetics

Lipids and diabetic retinopathy in newly diagnosed type 2 diabetics


Marketed By :  LAP LAMBERT Academic Publishing   Sold By :  Kamal Books International  
Delivery in :  10-12 Business Days

₹ 3,651

Availability: Out of stock


Delivery :

5% Cashback on all Orders paid using MobiKwik Wallet T&C

Free Krispy Kreme Voucher on all Orders paid using UltraCash Wallet T&C
Product Out of Stock Subscription

(Notify me when this product is back in stock)

  • Product Description

For the last few decades prevalence of diabetes mellitus is increasing alarmingly throughout the world with all its irreversible dreadful complications. Diabetic retinopathy is one of them and is a sight threatening condition. Along with hyperglycaemia in diabetic patients dyslipidaemia is one of the modifiable risk factors. Dyslipidaemia not only worsens preexisting endothelial dysfunction and injury but also may induce the same. With this idea in mind an attempt was made to evaluate the role of dyslipidaemia in the development of diabetic retinopathy in newly diagnosed type 2 diabetes mellitus. A case control study was done involving 85 newly diagnosed type 2 diabetes mellitus subjects with and without retinopathy. At the end of this work it was clearly evident that hyperglycaemia, hypertriglyceridaemia and low levels of HDL-C are associated with diabetic retinopathy. So intensified lipid lowering treatment strategy from the very beginning at diagnosis of diabetes might be beneficial in the prevention of diabetic retinopathy and other atherosclerosis related complications as vasculopathy plays the key role in all these chronic complications.

Product Specifications
SKU :COC25185
Country of ManufactureIndia
Product BrandLAP LAMBERT Academic Publishing
Product Packaging InfoBox
In The Box1 Piece
Product First Available On ClickOnCare.com2015-07-29
0 Review(s)